Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer

被引:17
|
作者
Chen, Feilong [1 ]
Xiao, Mei [2 ]
Hu, Shaofan [3 ]
Wang, Meng [3 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Expert Ctr Sichuan Prov, Sports Med Key Lab Sichuan Prov, Chengdu, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China
[3] Third Mil Med Univ, Mil Med Univ 3, Dept Biochem & Mol Biol, Chongqing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国博士后科学基金;
关键词
Keap1; Nrf2; cancer; structure; function; transcriptional regulation; prevention; clinical; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; SIGNALING PATHWAY; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; LUNG-CANCER; ACTIVATION;
D O I
10.3389/fonc.2024.1381467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells. Notably, oxidative stress is also considered a marker of cancer in humans. Keap1-Nrf2 signaling pathway, as a typical antioxidant stress pathway, is abnormal in a variety of human malignant tumor diseases (such as lung cancer, liver cancer, and thyroid cancer). In recent years, research on the Keap1-Nrf2 signaling pathway has become increasingly in-depth and detailed. Therefore, it is of great significance for cancer prevention and treatment to explore the molecular mechanism of the occurrence and development of this pathway.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Keap1-Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
    Kensler, Thomas W.
    Egner, Patricia A.
    Agyeman, Abena S.
    Visvanathan, Kala
    Groopman, John D.
    Chen, Jian-Guo
    Chen, Tao-Yang
    Fahey, Jed W.
    Talalay, Paul
    NATURAL PRODUCTS IN CANCER PREVENTION AND THERAPY, 2013, 329 : 163 - 177
  • [32] The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment
    Taguchi, Keiko
    Yamamoto, Masayuki
    CANCERS, 2021, 13 (01) : 1 - 21
  • [33] Somatic Mutations in KEAP1-NRF2 Complex in Breast Cancer
    Almeida, Micaela
    Ferreira, Catarina L.
    Tome, Rosa Maria
    Fonseca-Moutinho, Jose
    Polonia, Antonio
    Ramalhinho, Ana Cristina
    Breitenfeld, Luiza
    CANCERS, 2024, 16 (13)
  • [34] Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane
    Kensler, Thomas W.
    ANTI-CANCER DRUGS, 2015, 26 : E3 - E4
  • [35] Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
    Kamble, Dinisha
    Mahajan, Megharani
    Dhat, Rohini
    Sitasawad, Sandhya
    CELLS, 2021, 10 (01) : 1 - 21
  • [36] Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
    Jiang-Jiang Qin
    Xiang-Dong Cheng
    Jia Zhang
    Wei-Dong Zhang
    Cell Communication and Signaling, 17
  • [37] Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
    Qin, Jiang-Jiang
    Cheng, Xiang-Dong
    Zhang, Jia
    Zhang, Wei-Dong
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
  • [38] New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations
    Cheng, Liangkai
    Wang, Huihui
    Li, Shehan
    Liu, Zhongqiu
    Wang, Caiyan
    LIFE SCIENCES, 2021, 282
  • [39] Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation
    Li, Zhuang
    Mo, Rong-liang
    Gong, Jun-feng
    Han, Lin
    Wang, Wen-fei
    Huang, Da-ke
    Xu, Jie-gou
    Sun, Yan-jun
    Chen, Shuo
    Han, Gen-cheng
    Sun, Deng-qun
    PHYTOMEDICINE, 2024, 129
  • [40] The KEAP1-NRF2 System and Neurodegenerative Diseases
    Uruno, Akira
    Yamamoto, Masayuki
    ANTIOXIDANTS & REDOX SIGNALING, 2023, 38 (13) : 974 - 988